- In October 2022, MI Americas commenced the production of latex gloves and a range of other medical products at the former Ameritex Corporation facility in Alabama
- In April 2022, production of surgical latex gloves was initiated in Kyrgyzstan through a partnership with the Agency for Development of the Pharmaceutical Industry under the Ministry of Health of Uzbekistan and Ayu Pharm LLC
- In April 2022, the U.S. Food and Drug Administration granted 510(k) clearance to Showa Group for its biodegradable, single-use nitrile medical gloves, which are made from nitrile butadiene latex
- In December 2020, Ansell, an Australia-based company specializing in the production of protective industrial and medical gloves, acquired Primus Gloves for an undisclosed sum. This acquisition aims to secure the Primus brand and associated assets related to Primus Gloves' life science business
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Examination Gloves and Surgical Gloves), Product (Sterile and Non-sterile), Form (Powdered Form Gloves and Powder-Free Form Gloves), End user (Hospital, Clinic, Ambulatory Surgery Center, Diagnostic Imaging Center, and Rehabilitation Center) – Industry Trends and Forecast to 2031
.
The Global Latex Medical Gloves Market size was valued at USD 2.48 USD Billion in 2023.
The Global Latex Medical Gloves Market is projected to grow at a CAGR of 6.77% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
